Insulin resistance in nodular thyroid disease

Endocrine Research

Volumn 36, Issue 4, 2011, Pages 167-174

  Yasar, Hamiyet Yilmaz ^a   Ertuǧrul, Özden ^a   Ertuǧrul, Blent ^b   Ertuǧrul, Derun ^c   Şahin, Mustafa ^d  

^a Aydiin State Hospital   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

^c Keçiören Research and Training Hospital ^*  (Turkey)

^d Gaziantep 25 Aralik Hospital   (Turkey)

Author keywords

Insulin resistance; Insulin like growth factor; Thyroid nodules

Indexed keywords

FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIOTHYRONINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; ASPIRATION BIOPSY; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIOTHYRONINE BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NODULAR THYROID DISEASE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; THYROID CANCER; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TUMOR VOLUME; WAIST CIRCUMFERENCE;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; THYROID NODULE; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; YOUNG ADULT;

EID: 80053623213     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.3109/07435800.2011.593011     Document Type: Article

References (24)

1. Resnick HE, Jones K, Ruotolo G, et al. Insulin resistance, the metabolic syndrome and risk of incident cardiovascular disease in nondiabetic American Indians. Diabetes Care 2003;26:861-867. (Pubitemid 36929356)
2. Wilson PW. Estimating cardiovascular disease risk and the metabolic syndrome: A Framingham view. Endocrinol Metab Clin North Am2004;33:467-481. (Pubitemid 38953883)
3. Eckel RH, Grundy SM, Zimmet PZ. Themetabolic syndrome. Lancet 2005;365:1415-1428.
4. Wellen KE, Hotamisligil GS. Inflammation, stress and diabetes. J Clin Invest 2005;115:1111-1119.
5. Roith DL, Zick Y. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 2001;24:588-597. (Pubitemid 32198431)
6. Vella V, Sciacca L, Pandini G, et al. The IGF-1 system in thyroid cancer: New concepts. Mol Pathol 2001;54:121-125.
7. Rezzonico J, Rezzonico M, Pusiol E, Pitoia F, Niepomniszcze H. Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid 2008;18:461-464. (Pubitemid 351519543)
8. Ayturk S, Gursoy A, Kut A, Anil C, Nar A, Tutuncu NB. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodinedeficient area. Eur J Endocrinol 2009;161(4):599-605.
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations inman. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
10. Delange F, Benker G, Caron P, et al. Thyroid volume and urinary iodine in European schoolchildren: Standardization of values for assessment of iodine deficiency. Eur J Endocrinol 1997;136: 180-187. (Pubitemid 27096347)
11. Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC. Volumetric analysis of thyroid lobes by realtime ultrasound. DtschMedWochenschr 1981;106:1338-1340. (Pubitemid 11020280)
12. Gordon DL, Flisak M, Fisher SG. Changes in thyroid nodule volume caused by fine-needle aspiration: A factor complicating the interpretation of the effect of thyrotropin suppression on nodule size. J Clin EndocrinolMetab 1999;84:4566-4569.
13. Banks WA, Willoughby LM, Thomas DR, Morley JE. Insulin resistance syndrome in the elderly: Assessment of functional, biochemical, metabolic, and inflammatory status. Diabetes Care 2007;30:2369-2373. (Pubitemid 47359048)
14. Knudsen N, Laurberg P, Rasmussen LB, et al. Small differences in thyroid function may be important for body mass index and occurrence of obesity in the population. J Clin Endocrinol Metab 2005;90:4019-4024. (Pubitemid 41058166)
15. Kim BJ, Kim TY, Koh JM, et al. Relationship between serumfree T4 levels and metabolic syndrome and its components in healthy euthyroid subjects. Clin Endocrinol 2009;70:152-160.
16. Sari S, Balci MK, Altunba̧s H, Karayalçin U. The effect of body weight and weight loss on thyroid volume and function in obese women. Clin Endocrinol 2003;59:258-262. (Pubitemid 36918663)
17. Rosenbaum M, Hirsch J, Murphy E, Leibel RL. Effects of changes in body weight on carbohydrate metabolism, cathecolamine excretion and thyroid function. Am J Clin Nutr 2000;71:1421-1432. (Pubitemid 30395887)
18. Lewandowski K, Randeva HS, O'Callaghan CJ, et al. Effects of insulin and glucocorticoids on the leptin system aremediated through free leptin. Clin Endocrinol 2001;54:533-539. (Pubitemid 34204190)
19. Menendez C, Baldelli R, Camina JP, et al. TSH stimulates leptin secretion by a direct effect on adipocytes. J Endocrinol 2003;176:7-12. (Pubitemid 36163561)
20. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM. The thyrotropin (TSH) receptor: Interaction with TSH and autoantibodies. Endocr Rev 1998;19:673-716. (Pubitemid 128506520)
21. Van der Laan BF, Freeman JL, Asa SL. Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues. Thyroid 1995;5:67-73.
22. Frittita L, Sciacca L, Catalfamo R. Functional insulin receptors are overexpressed in thyroid tumors. Cancer 1999;85:492-498.
23. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-1, IGF binding protein-3 and cancer risk: Systematic review and meta-regression analysis. Lancet 2004;24:1346-1353. (Pubitemid 38529873)
24. Tita P, Ambrosio MR, Scollo C, et al. High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol 2005;63:161-167. (Pubitemid 41097984)